Chemopreventive potential of curcumin monoglucuronide in mouse Pten-null prostate cancer

被引：0
|
作者：
Kura, Yurie [1 ,2 ]
Develasco, Marco A. [1 ,2 ]
Sakai, Kazuko [2 ]
Fujita, Kazutoshi [1 ]
Banno, Eri [1 ]
Fujita, Yoshihiko [2 ]
Hashimoto, Mamoru [1 ]
Nishimoto, Mituhisa [1 ]
Nozawa, Masahiro [1 ]
Yoshimura, Kazuhiro
Kakeya, Hideaki [1 ,3 ]
Uemura, Hirotsugu
Nishio, Kazuto [2 ]
机构：
[1] Kindai Univ, Fac Med, Dept Urol, Higashiosaka, Japan
[2] Kindai Univ, Fac Med, Dept Genome Biol, Higashiosaka, Japan
[3] Kyoto Univ, Grad Sch Pharm Sci, Kyoto, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2387
引用
收藏
页码：1272 / 1272
页数：1
相关论文
共 50 条
  • [21] AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer
    Khan, Mohammad Imran
    Hamid, Abid
    Rath, Suvasmita
    Ateeq, Bushra
    Khan, Qateeb
    Siddiqui, Imtiaz A.
    Adhami, Vaqar Mustafa
    Choudhry, Hani
    Zamzami, Mazin A.
    Mukhtar, Hasan
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (02) : 356 - 363
  • [22] Vemurafenib Inhibits Active PTK6 in PTEN-null Prostate Tumor Cells
    Wozniak, Darren J.
    Hitchinson, Ben
    Gilic, Milica B.
    Bie, Wenjun
    Gaponenko, Vadim
    Tyner, Angela L.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (05) : 937 - 946
  • [23] Investigating Novel Roles for FOXO factors in pten-null Cancer Cells.
    Martinez, E.
    Fanniel, V.
    Sanchez, L.
    Vazquez, N.
    Marks, R.
    Salinas, A.
    Sanchez, L.
    Hirschmann, J.
    Lopez, A.
    Innis, W.
    Keniry, M. E.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [24] Chemopreventive effects of nanoparticle curcumin in a mouse model ofPten-deficient prostate cancer
    De Velasco, Marco A.
    Lu, Yan
    Kura, Yurie
    China, Toshiyuki
    Inoue, Yasuyuki
    Nakayama, Akinori
    Okada, Hiroshi
    Horie, Shigeo
    Uemura, Hirotsugu
    Ide, Hisamitsu
    HUMAN CELL, 2020, 33 (03) : 730 - 736
  • [25] Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells
    Hua, Sheng
    Yao, Mu
    Vignarajan, Soma
    Witting, Paul
    Hejazi, Leila
    Gong, Zhen
    Teng, Ying
    Niknami, Marzieh
    Assinder, Stephen
    Richardson, Des
    Dong, Qihan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (06): : 1146 - 1157
  • [26] Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer
    Sinha, Dona
    Biswas, Jaydip
    Sung, Bokyung
    Aggarwal, Bharat B.
    Bishayee, Anupam
    CURRENT DRUG TARGETS, 2012, 13 (14) : 1799 - 1819
  • [27] Analysis of Pten-null mouse astrocytes revealed overlapping transcribed genes with human glioblastoma transcriptome
    Liu, Tian
    Or, Penelope Mei-Yu
    Wong, Chi-Wai
    Cheung, Stanley Kwok-Kuen
    Wang, Yubing
    Wang, Yiwei
    Chan, Andrew M.
    CANCER RESEARCH, 2020, 80 (16)
  • [28] Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer
    Kappler, Christiana S.
    Guest, Stephen T.
    Irish, Jonathan C.
    Garrett-Mayer, Elizabeth
    Kratche, Zachary
    Wilson, Robert C.
    Ethier, Stephen P.
    MOLECULAR ONCOLOGY, 2015, 9 (02) : 527 - 543
  • [29] Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment
    Qi, Zhi
    Xu, Zihan
    Zhang, Liuzhen
    Zou, Yongkang
    Li, Jinping
    Yan, Wenyu
    Li, Cheng
    Liu, Ningshu
    Wu, Hong
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [30] Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment
    Zhi Qi
    Zihan Xu
    Liuzhen Zhang
    Yongkang Zou
    Jinping Li
    Wenyu Yan
    Cheng Li
    Ningshu Liu
    Hong Wu
    Nature Communications, 13
12345